Upper Gastrointestinal Biopsy
Publication Date: October 1, 2015
Key Points
Key Points
- The purpose of the current guideline is to establish evidence-based practicing standards for the performance of biopsies of normal-appearing mucosa in the upper gastrointestinal tract.
- Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
- The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.
Diagnosis
...iagnosi...
...III Criteria for Functional Dyspep...
...er-Gastrointestinal Biopsy to Evaluate Dyspepsia i...
...Recommendations from the AGA Guidelin...
...tients undergoing EGD for dyspepsia as the sole...
...n immunocompetent patients undergoing EGD for...
...immunocompromised patients undergoing EGD for...
...taining biopsies from the normal-ap...
...opsies are obtained from the normal-app...
...In patients undergoing EGD for dyspepsia a...
...immunocompromised patients undergoing E...
...psies are obtained from the normal-appearing...
...cations of Gastric Biopsy Recommended b...